Paclitaxel and tamoxifen

This publication has 15 references indexed in Scilit:

• Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
  Journal of Clinical Oncology, 1998
• Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites
  British Journal of Cancer, 1993
• A phase I trial of taxol given by a 6-hour intravenous infusion.
  Journal of Clinical Oncology, 1991
• Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype [see comments]
  Blood, 1991
• A phase II study of taxol in patients with malignant melanoma
  Investigational New Drugs, 1991
• A phase II trial of taxol in metastatic melanoma
  Cancer, 1990
• Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.
  Journal of Clinical Oncology, 1989
• The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma
  Cancer, 1989
• Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate
  Cancer Chemotherapy and Pharmacology, 1988
• Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
  Journal of the American Chemical Society, 1971